Evidence map›Paper›PMID 31865604›Full record

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2020

Is one brachytherapy fraction of 7 Gy similar to more fractions after external beam irradiation in postoperative endometrial carcinoma?

Y Zhang, C Ascaso, A Herreros, J Sánchez, M Del Pino, A Torné, Y Li, S Sabater, M Arenas, A Biete and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Consensus and recommendations on vaginal-cuff Brachytherapy of the Spanish Brachytherapy Groups of SEOR and SEFM.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2021
    Guideline
  2. D90 and DCancers · 2026
    Article
  3. Article
  4. Article
  5. Preliminary results of a vaginal constraint for reducing G2 late vaginal complications after postoperative brachytherapy in endometrial cancer: a prospective analysis.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Y ZhangRadiation Oncology Department, Hospital Clinic I Universitari, C/ Villarroel 170, 08036, Barcelona, Spain.ORCID http://orcid.org/0000-0002-2379-6174
C AscasoFonaments Clinics Department, Faculty of Medicine, University of Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0002-4895-7616
A HerrerosRadiation Oncology Department, Hospital Clinic I Universitari, C/ Villarroel 170, 08036, Barcelona, Spain.ORCID http://orcid.org/0000-0001-9867-481X
J SánchezEconomics Department, Hospital Clinic I Universitari, Barcelona, Spain.ORCID http://orcid.org/0000-0001-5075-2516
M Del PinoGynecological Cancer Unit, Gynecological and Obstetrics Department, Hospital Clinic I Universitari, Barcelona, Spain.ORCID http://orcid.org/0000-0002-7965-4757
A TornéGynecological Cancer Unit, Gynecological and Obstetrics Department, Hospital Clinic I Universitari, Barcelona, Spain.ORCID http://orcid.org/0000-0003-4700-9507
Y LiRadiation Oncology Department, Hospital Clinic I Universitari, C/ Villarroel 170, 08036, Barcelona, Spain.
S SabaterRadiation Oncology Department, Hospital General Universitario de Albacete, Albacete, Spain.ORCID http://orcid.org/0000-0003-0111-9540
M ArenasRadiation Oncology Department, Hospital San Joan de Reus, Reus, Spain.ORCID http://orcid.org/0000-0003-0815-2570
A BieteRadiation Oncology Department, Hospital Clinic I Universitari, C/ Villarroel 170, 08036, Barcelona, Spain.ORCID http://orcid.org/0000-0001-6049-2025
Á RovirosaRadiation Oncology Department, Hospital Clinic I Universitari, C/ Villarroel 170, 08036, Barcelona, Spain. rovirosa@ub.edu.ORCID http://orcid.org/0000-0002-7832-334X
Hospital Universitari de Vic · ESCancer Clinic · USHospital General Universitario de Albacete · ESHospital Universitari Sant Joan de Reus · ESUniversitat de Barcelona · ES

Funding

Fundación Científica Asociación Española Contra el Cáncer PS141526ROVI
6 · The paper itself

Abstract

purposeTo determine whether brachytherapy with a single hypofractionated dose of 7 Gy provides the similar vaginal-cuff relapses and safety profile in terms of complications compared to schedules of 2 or 3 fractions of lower doses in patients treated previously with external beam irradiation in postoperative endometrial carcinoma. METHODS/MATERIAL: From June 2003 to December 2016, 325 patients were treated with 3 different schedules of high-dose-rate brachytherapy after external beam irradiation for postoperative endometrial carcinoma. The patients were divided into 3 groups: Group-1: 125 patients were treated with 3 fractions of 4-6 Gy per fraction (3 fractions/week) between 2003 and 2008; Group-2: 93 patients were treated with 2 consecutive daily fractions of 5-6 Gy between 2008 and 2011; Group-3: 107 patients received a single fraction of 7 Gy between 2011 and 2016. Bladder and rectum complications were assessed using RTOG scores and with the objective scores of LENT-SOMA for the vagina. STATISTICS: the chi-square test.

resultsThe mean follow-up of Groups 1, 2 and 3 was 95, 67 and 51 months, respectively. Three patients in Group-1, 2 in Group-2, 1 in Group-3 developed vaginal-cuff relapse (p = 0.68). No differences were found in late toxicity among the three groups.

conclusionsOne single dose of 7 Gy is safe and effective and may be the best treatment schedule with a similar incidence of vaginal-cuff relapses, complications and patient comfort with less hospital attendance.

Indexed as

BrachytherapyDose Fractionation, RadiationAgedChi-Square DistributionEndometrial NeoplasmsFemaleHumansOrgans at RiskPostoperative PeriodRadiation Dose HypofractionationRectumUrinary BladderVaginaBrachytherapy fractionation schedulesEndometrial carcinomaPostoperative radiotherapy

Identifiers

PMID31865604
OpenAlexW2995037494

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.